Difference between revisions of "Suramin (Antrypol)"
Jump to navigation
Jump to search
m |
m |
||
Line 14: | Line 14: | ||
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
[[Category:Antiparasitic]] | [[Category:Antiparasitic]] | ||
+ | [[Category:WHO Essential Anti-infective Medicines]] | ||
[[Category:Stub]] | [[Category:Stub]] |
Latest revision as of 02:09, 30 July 2023
Mechanism of action
Antiparasitic with mechanism of action unclear.
Diseases for which it was used
History of changes in FDA indication
- This drug is not FDA approved. Of note, it was investigated in prostate cancer but utility was not proven and investigations have been discontinued.
Also known as
- Brand name: Antrypol